Recent News for STRO - Sutro Biopharma, Inc.

Date Title
Aug 8 Sutro Biopharma to Present at the 2019 Wedbush PacGrow Healthcare Conference
Jul 31 Is Sutro Biopharma (NASDAQ:STRO) Using Debt In A Risky Way?
Jul 18 Wainwright sees 310% upside in Outlook Therapeutics in premarket analyst action
Jul 4 Here’s What Hedge Funds Think About Sutro Biopharma, Inc. (STRO)
Jun 24 Sutro Biopharma Appoints Biopharma Veteran Connie Matsui as Board Chair
Jun 18 Sutro Biopharma to Present at the JMP Securities Life Sciences Conference
Jun 15 Sutro Biopharma Announces Encouraging Interim Phase 1 Safety Data on a Potential First-in-Class Antibody-Drug Conjugate STRO-001 for the Treatment of B-cell Malignancies at the European Hematology Association Congress
May 16 Sutro Biopharma Announces Presentation at the 2019 European Hematology Association Congress
May 15 Sutro Biopharma Reports First Quarter 2019 Financial Results and Recent Business Highlights and Developments
May 8 Sutro Biopharma (STRO) Presents At Deutsche Bank 44th Annual Health Care Conference - Slideshow
May 7 Celgene backs away from collaboration programs with Sutro
Apr 29 Sell-siders bullish on recent IPOs NGM Biopharma and Silk Road Medical
Apr 8 How free-flowing cash is accelerating small companies' cancer drug trials
Apr 4 Sutro Biopharma to Present at the 18th Annual Needham Healthcare Conference
Apr 1 Sutro Biopharma EPS of -$6.13
Apr 1 Sutro Biopharma Reports Full Year 2018 Financial Results and Recent Business Highlights and Developments
Mar 15 Sutro Biopharma Initiates Phase I Clinical Trial of STRO-002 for the Treatment of Ovarian and Endometrial Cancers
Mar 5 Sutro Biopharma to Present at the Cowen and Company 39th Annual Health Care Conference
Back to the Main STRO Page...